Answers are grounded in this paper and cite their sources.
Elevated circulating FGF-23 levels and defects in skeletal mineralization early in the course of CKD suggest that factors other than the traditional markers of mineral deficiency play a crucial role in the development of renal bone disease.
No takes yet. Share an insight, caveat, or question.
Wesseling‐Perry et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: